Walgreens Boots Alliance (NASDAQ:WBA) has been given a $61.00 price target by research analysts at Morgan Stanley in a research report issued to clients and investors on Tuesday, Stock Target Advisor reports. The firm presently has a “hold” rating on the pharmacy operator’s stock. Morgan Stanley’s target price would indicate a potential upside of 15.66% from the stock’s current price.
WBA has been the topic of several other reports. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, February 14th. UBS Group started coverage on Walgreens Boots Alliance in a research note on Thursday, January 17th. They set a “sell” rating and a $70.00 target price on the stock. Loop Capital set a $82.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Wednesday, January 23rd. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, February 26th. Finally, Robert W. Baird cut their target price on Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating on the stock in a research note on Friday, March 1st. Five analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $68.00.
Walgreens Boots Alliance stock opened at $52.74 on Tuesday. The company has a current ratio of 0.78, a quick ratio of 0.38 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $47.65 billion, a P/E ratio of 8.76, a P/E/G ratio of 1.06 and a beta of 0.77. Walgreens Boots Alliance has a twelve month low of $51.79 and a twelve month high of $86.31.
In other news, COO Ornella Barra purchased 18,000 shares of the stock in a transaction dated Wednesday, April 3rd. The shares were purchased at an average cost of $54.56 per share, with a total value of $982,080.00. Following the acquisition, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at $1,441,748. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the transaction, the chief accounting officer now directly owns 435,811 shares in the company, valued at $23,119,773.55. The disclosure for this sale can be found here. 15.73% of the stock is owned by corporate insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Neuberger Berman Group LLC raised its holdings in Walgreens Boots Alliance by 18.8% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,108,521 shares of the pharmacy operator’s stock worth $80,812,000 after purchasing an additional 175,525 shares during the period. Vanguard Group Inc raised its holdings in Walgreens Boots Alliance by 0.6% in the 3rd quarter. Vanguard Group Inc now owns 70,634,071 shares of the pharmacy operator’s stock worth $5,149,224,000 after purchasing an additional 448,045 shares during the period. LVM Capital Management Ltd. MI increased its stake in Walgreens Boots Alliance by 29.1% in the 4th quarter. LVM Capital Management Ltd. MI now owns 3,909 shares of the pharmacy operator’s stock worth $267,000 after buying an additional 882 shares in the last quarter. QUANTRES ASSET MANAGEMENT Ltd purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth $4,988,000. Finally, Founders Capital Management LLC increased its stake in Walgreens Boots Alliance by 5.0% in the 4th quarter. Founders Capital Management LLC now owns 162,893 shares of the pharmacy operator’s stock worth $11,130,000 after buying an additional 7,749 shares in the last quarter. 64.77% of the stock is currently owned by hedge funds and other institutional investors.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: Different Options Trading Strategies
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.